Clinical value of continuous administration of sorafenib in combination with modified transarterial chemoembolization in patients with unresectable hepatocellular carcinoma.
- Author:
Yong-Hui HUANG
1
;
Wei CHEN
;
Jia-Ping LI
;
Bin CHEN
;
Jian-Yong YANG
Author Information
1. Department of Interventional Radiology, First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510080, China.
- Publication Type:Journal Article
- MeSH:
Aged;
Aged, 80 and over;
Antineoplastic Agents;
therapeutic use;
Carcinoma, Hepatocellular;
mortality;
therapy;
Chemoembolization, Therapeutic;
Combined Modality Therapy;
Disease-Free Survival;
Humans;
Liver Neoplasms;
mortality;
therapy;
Middle Aged;
Niacinamide;
analogs & derivatives;
therapeutic use;
Phenylurea Compounds;
therapeutic use
- From:
Chinese Medical Journal
2013;126(2):385-386
- CountryChina
- Language:English
